Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
Market Cap$114.75M
Close$
$20.34
2768.6% upside
Current Fair Value
2768.6% upsideUndervalued by 2768.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $114.75 Million |
|---|---|
| Enterprise Value | $628.23 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0.01 |
| Beta | 0.37 |
| Outstanding Shares | 159,895,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 3.88 |
|---|---|
| PEG | 3.77 |
| Price to Sales | 0.35 |
| Price to Book Ratio | -0.35 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | 5.9 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | -2 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ironwood Pharmaceuticals Inc
CEO: Mark Mallon